Osteoclast Dynamics in Bone Remodeling

Bone remodelling is sustained by the coordinated actions of osteoclasts, which resorb mineralised matrix, and osteoblasts, which deposit new bone. Osteoclasts arise from monocyte–macrophage precursors under the influence of macrophage colony-stimulating factor (M-CSF) and RANKL, undergoing fusion to form multinucleated cells. Their resorptive function relies on dynamic reorganisation of the actin cytoskeleton into podosomes, which coalesce into a sealing zone to isolate the resorption lacuna and a ruffled border to secrete acid and proteases. Key signalling pathways—such as PI3K/Akt, Src, NFATc1 and Rho family GTPases—regulate differentiation, adhesion, motility and resorption. Dysregulation of these processes underlies conditions from osteoporosis to cancer-associated bone lesions. Understanding the molecular controls of osteoclast fusion, cytoskeletal remodelling and secretory function has direct implications for therapies aimed at preserving skeletal integrity in metabolic, inflammatory and neoplastic diseases.

Research from Nature Portfolio

Recent studies have illuminated novel regulators of osteoclast fusion and resorptive capacity. One investigation identified the programmed death-1 homologue PD-1H as a critical receptor for a myeloma-derived metalloproteinase, demonstrating that ablation of PD-1H impairs cytoskeletal sealing zone formation and attenuates bone destruction in a myeloma model. These findings reveal an unexpected immunoregulatory axis in bone resorption and suggest targeting the PD-1H signalling interface to mitigate lytic lesions. Another report uncovered the role of the haematopoietic-specific WAVE-complex subunit Hem1 in ruffled border architecture. Loss of Hem1 promotes osteoclast differentiation but disrupts sealing zone morphology and vesicular trafficking, leading to defective bone degradation despite elevated osteoclast numbers. This work defines Hem1 as a key structural mediator of actin reorganisation necessary for efficient bone resorption.

Osteoclast Dynamics in Bone Remodeling publication trend

The graph below shows the total number of articles in osteoclast dynamics in bone remodeling across all publications each year (not limited to Nature Index journals).

Technical terms

Osteoclast: A multinucleated cell derived from monocyte–macrophage precursors that degrades bone matrix during remodelling.

Sealing zone: A ring-like adhesion structure formed by reorganised podosomes that isolates the resorption lacuna during bone degradation.

Ruffled border: A highly folded plasma membrane domain on the bone-facing surface of osteoclasts where acid and proteases are secreted to dissolve mineral and matrix.

RANKL: Receptor activator of nuclear factor κB ligand, a key cytokine that drives osteoclast differentiation and activation.

NFATc1: Nuclear factor of activated T cells c1, the master transcription factor required for osteoclastogenesis and expression of resorptive genes.

WAVE complex: A multiprotein complex that regulates actin polymerisation downstream of Rac GTPase, crucial for membrane protrusions and cytoskeletal organisation.

GTPase: An enzyme that hydrolyses GTP, such as RhoA or Rac1, acting as a molecular switch in cytoskeletal and signalling pathways.

References

1. The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease. Nature Communications (2023).
2. Glia maturation factor beta deficiency protects against diabetic osteoporosis by suppressing osteoclast hyperactivity. Experimental & Molecular Medicine (2023).
3. RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling. Molecular Medicine (2023).
4. In Vitro Cell Culture Model for Osteoclast Activation during Estrogen Withdrawal. International Journal of Molecular Sciences (2024).
5. Hem1 is essential for ruffled border formation in osteoclasts and efficient bone resorption. Scientific Reports (2024).